News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
490,497 Results
Type
Article (25725)
Company Profile (109)
Press Release (464650)
Multimedia
Podcasts (73)
Webinars (18)
Section
Business (140328)
Career Advice (465)
Deals (20524)
Drug Delivery (78)
Drug Development (79692)
Employer Resources (47)
FDA (12858)
Job Trends (9373)
News (234319)
Policy (18713)
Tag
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (3)
2027 Genetown Standard (6)
2027 Pharm Country Standard (3)
Academia (1759)
Academic (1)
Accelerated approval (58)
ADA (40)
Adcomms (35)
Allergies (201)
Alliances (33757)
ALS (249)
Alzheimer's disease (1898)
Antibody-drug conjugate (ADC) (594)
Approvals (13494)
Artificial intelligence (739)
ASCO (343)
Autoimmune disease (407)
Automation (48)
Bankruptcy (150)
Belgium (4)
Best Places to Work (8156)
BIO (65)
Biologics (12)
BIOSECURE Act (12)
Biosimilars (188)
BioSpace Insights (88)
Biotechnology (87)
Bispecific (1)
Bladder cancer (217)
Brain cancer (83)
Breast cancer (851)
Cancer (6689)
Cardiovascular disease (527)
Career advice (433)
Career pathing (29)
CAR-T (370)
CDC (19)
CDMO (97)
Celiac Disease (4)
Cell therapy (967)
Cervical cancer (58)
Clinical research (72205)
Collaboration (2124)
Commercialization (11)
Company closure (5)
Compensation (1269)
Complete response letters (78)
COVID-19 (2191)
CRISPR (102)
C-suite (1253)
Cystic fibrosis (156)
Data (9328)
Decentralized trials (3)
Denatured (28)
Depression (198)
Dermatology (118)
Diabetes (625)
Diagnostics (5903)
Digital health (58)
Diversity (12)
Diversity, equity & inclusion (18)
Drug discovery (323)
Drug pricing (54)
Drug shortages (14)
Duchenne muscular dystrophy (304)
Earnings (52857)
Editorial (33)
Employer branding (3)
Employer resources (49)
Events (81334)
Executive appointments (1021)
FDA (17040)
Fibrodysplasia Ossificans Progressiva (10)
Fragile X (1)
Friedreich's ataxia (25)
Frontotemporal dementia (36)
Funding (1777)
Gene editing (225)
Generative AI (62)
Gene therapy (731)
GLP-1 (864)
Government (2416)
Grass and pollen (6)
Guidances (343)
Healthcare (14051)
Hematology (187)
HIV (83)
Huntington's disease (66)
IgA nephropathy (125)
Immunology and inflammation (298)
Immuno-oncology (120)
Indications (237)
Infectious disease (2510)
Inflammatory bowel disease (235)
Inflation Reduction Act (4)
Influenza (125)
Intellectual property (299)
Interviews (70)
IPO (11073)
IRA (13)
Job creations (1503)
Job search strategy (362)
JPM (32)
Kidney cancer (26)
Labor market (49)
Layoffs (349)
Leadership (25)
Legal (2303)
Licensing (22)
Liver cancer (99)
Longevity (39)
Lung cancer (925)
Lymphoma (491)
Machine learning (56)
Management (17)
Manufacturing (884)
Marketing (11)
MASH (220)
Medical affairs (3)
Medical device (9827)
Medtech (10027)
Mergers & acquisitions (10632)
Metabolic disorders (1481)
mRNA (194)
Multiple sclerosis (210)
NASH (15)
Netherlands (2)
Neurodegenerative disease (508)
Neuropsychiatric disorders (114)
Neuroscience (3649)
Neurotech (1)
NextGen: Class of 2026 (3884)
Non-profit (2466)
Now hiring (51)
Obesity (602)
Opinion (222)
Ovarian cancer (247)
Pain (286)
Pancreatic cancer (382)
Parkinson's disease (414)
Partnered (26)
Patents (600)
Patient advocacy (1)
Patient recruitment (942)
Patient selection (4)
Peanut (66)
People (40162)
Peptides (6)
Pharmaceutical (24)
Pharmacy benefit managers (13)
Phase 1 (23218)
Phase 2 (32131)
Phase 3 (23303)
Pipeline (11164)
Policy (139)
Postmarket research (2059)
Preclinical (8390)
Press Release (28)
Prostate cancer (346)
Psychedelics (70)
Radiopharmaceuticals (368)
Rare diseases (1194)
Real estate (2937)
Recruiting (21)
Regenerative medicine (2)
Regulatory (19700)
Reports (34)
Research institute (1947)
Resumes & cover letters (65)
Rett syndrome (51)
RNA editing (24)
RSV (63)
Schizophrenia (184)
Series A (330)
Series B (242)
Service/supplier (6)
Sickle cell disease (109)
Special edition (21)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (2452)
State (1)
Stomach cancer (16)
Supply chain (73)
Tariffs (16)
The Weekly (45)
Vaccines (868)
Venture capital (91)
Weight loss (334)
Women's health (141)
Worklife (8)
Date
Today (65)
Last 7 days (394)
Last 30 days (1976)
Last 365 days (26466)
2026 (19170)
2025 (25729)
2024 (29207)
2023 (33123)
2022 (41007)
2021 (42982)
2020 (39526)
2019 (30535)
2018 (22968)
2017 (23786)
2016 (21714)
2015 (25412)
2014 (18358)
2013 (13787)
2012 (14432)
2011 (14807)
2010 (13947)
Location
Africa (382)
Alabama (94)
Alaska (3)
Arizona (257)
Arkansas (9)
Asia (30051)
Australia (5862)
California (13412)
Canada (3310)
China (1606)
Colorado (553)
Connecticut (570)
Delaware (402)
Europe (69056)
Florida (1947)
Georgia (432)
Hawaii (3)
Idaho (42)
Illinois (884)
India (73)
Indiana (559)
Iowa (23)
Japan (609)
Kansas (116)
Kentucky (51)
Louisiana (49)
Maine (31)
Maryland (1397)
Massachusetts (9507)
Michigan (255)
Minnesota (547)
Mississippi (5)
Missouri (119)
Montana (32)
Nebraska (19)
Nevada (149)
New Hampshire (68)
New Jersey (3290)
New Mexico (26)
New York (3536)
North Carolina (1603)
North Dakota (8)
Northern California (6940)
Ohio (352)
Oklahoma (26)
Oregon (37)
Pennsylvania (2484)
Puerto Rico (20)
Rhode Island (34)
South America (497)
South Carolina (56)
South Dakota (1)
Southern California (5375)
Tennessee (208)
Texas (2290)
United States (45563)
Utah (357)
Vermont (2)
Virginia (304)
Washington D.C. (55)
Washington State (1040)
West Virginia (2)
Wisconsin (120)
Wyoming (1)
490,497 Results for "quotient clinical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Quotient Therapeutics Appoints Seasoned Life Sciences Executive, Susan Keefe, as Chief Financial Officer
February 2, 2026
·
2 min read
Press Releases
Quotient Therapeutics Announces Collaboration with Merck to Discover Novel Drug Targets in Inflammatory Bowel Disease Using Somatic Genomics Platform Technology
March 24, 2026
·
2 min read
Press Releases
Flagship Pioneering Announces New Agreements with ProFound Therapeutics and Quotient Therapeutics Under its Collaboration with GSK
November 21, 2025
·
5 min read
Press Releases
Quotient Therapeutics Appoints Drug Discovery and Development Veteran, Andrew Bayliffe, as Chief Development Officer
September 30, 2025
·
2 min read
Collaboration
Pfizer Partners With Flagship’s Quotient to Leverage Genetics Against Heart, Renal Diseases
Quotient Therapeutics’ platform targets somatic mutations, which the startup contends can help identify a broader scope of genes potentially associated with disease phenotypes. Wednesday’s agreement is part of an existing partnership between Pfizer and Flagship Pioneering.
August 28, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Kiora Pharmaceuticals Appoints Keith J. Lane as Executive Vice President of Global Clinical Development and Regulatory Affairs
Clinical development executive brings over 20 years of ophthalmology experience supporting U.S. and global clinical trials to support the advancement of Kiora’s pipeline and new asset opportunities
September 8, 2026
·
2 min read
Press Releases
Clinical Science Update | New Clinical Evidence for ClotChek™
September 8, 2026
·
2 min read
Press Releases
ConV2X Releases Final Agenda Focused on AI, Clinical Development, FDA Regulation and Pharmaceutical Data Integrity
ConV2X Releases Final Agenda Focused on AI, Clinical Development, FDA Regulation and Pharmaceutical Data Integrity
September 8, 2026
·
1 min read
Mergers & acquisitions
Stripped of AstraZeneca safety net, BMS could face ‘carnage’ if high-risk clinical trial fails
BMS is barreling toward a clinical trial readout that an H.C. Wainwright analyst believes could contribute to the return of mergers between mega-cap drugmakers.
September 2, 2026
·
5 min read
·
Nick Paul Taylor
Press Releases
Hemostemix Commercializes Its Vascular Dementia Clinical Trial of VesCell(TM) Under LARTA
Leading cognitive-disorders specialist, Dr. William Shankle, will discuss vascular cognitive impairment, vascular dementia and the proposed clinical trial of VesCell™ (ACP-01) today at 12:00 EST, at https://us06web.zoom.us/webinar/register/WN_nJ8ViLkRSeiU_NXMYJ-jbw
August 20, 2026
·
12 min read
1 of 49,050
Next
